Literature DB >> 12356120

Panic attacks associated with citalopram.

Heidi R Brauer1, Paul W Nowicki, Glenn Catalano, Maria C Catalano.   

Abstract

Citalopram is the newest selective serotonin reuptake inhibitor (SSRI) available in the United States. It is currently approved by the Food and Drug Administration for the treatment of major depression. However, a number of studies have found it to be effective in the treatment of panic disorder as well. While there have been no previous case reports of citalopram inducing panic attacks in patients, this phenomenon has been reported with other members of the SSRI class of antidepressants. We present the case of a 61-year-old woman who had frank panic attacks after her citalopram dose was increased. She had had no history of anxiety symptoms. Anxiety abated completely upon discontinuance of citalopram therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356120

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.

Authors:  L Mathiasen; N R Mirza
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 2.  Pharmacological treatment of vertigo.

Authors:  Timothy C Hain; Mohammed Uddin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Medication dependence and anxiety.

Authors:  Lisa L von Moltke; David J Greenblatt
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

Review 4.  Achieving adolescent adherence to treatment of major depression.

Authors:  Dennis Staton
Journal:  Adolesc Health Med Ther       Date:  2010-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.